tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Income Statement

Compare
4,057 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q4 2025), Sarepta Therapeutics's total revenue was $442.93M, a decrease of -32.73% from the same quarter last year. In Q4, Sarepta Therapeutics's net income was $-282.85M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.20B$ 1.90B$ 1.24B$ 933.01M$ 701.89M
Gross Profit
$ 1.32B$ 1.58B$ 1.09B$ 793.02M$ 604.84M
Operating Expenses
$ 1.97B$ 1.36B$ 1.36B$ 1.33B$ 1.06B
Depreciation and Amortization
$ 44.52M$ 37.72M$ 44.40M$ 41.86M$ 38.02M
EBITDA
$ -647.97M$ 316.89M$ -453.69M$ -594.85M$ -317.41M
Operating Income
$ -657.77M$ 218.08M$ -267.82M$ -536.20M$ -459.71M
Other Income/Expenses
$ -44.45M$ 42.69M$ -252.27M$ -153.76M$ 40.76M
Pretax Income
$ -702.23M$ 260.77M$ -520.10M$ -689.96M$ -418.95M
Net Income
$ -713.41M$ 235.24M$ -535.98M$ -703.49M$ -418.78M
Per Share Metrics
Basic EPS
$ -7.13$ 2.47$ -5.80$ -8.03$ -5.15
Diluted EPS
$ -7.13$ 2.34$ -5.80$ -8.03$ -5.15
Weighted Average Shares Outstanding
104.79M 95.08M 92.40M 87.56M 81.26M
Weighted Average Shares Outstanding (Diluted)
104.79M 107.88M 92.40M 87.56M 81.26M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History